Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir
Mohideen M, Quijano E, Song E, Deng Y, Panse G, Zhang W, Clark MR, Saltzman WM. Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir. Biomaterials 2017, 144: 144-154. PMID: 28829952, PMCID: PMC5581224, DOI: 10.1016/j.biomaterials.2017.08.029.Peer-Reviewed Original ResearchConceptsPolymer carrierPolymeric nanoparticlesIntravaginal deliveryBioadhesive nanoparticlesNanoparticlesHuman immunodeficiency virusPromising strategyProtective mucus layerReproductive tractFormulation 1Residence timePolyEpithelial cell populationsSite of actionImmunodeficiency virusRetentionIntravaginal administrationVaginal lumenMucosal surfacesSustained protectionTopical applicationSTD epidemicsElvitegravirHormone cyclesMucus layerThe skin as a window to the blood: Cutaneous manifestations of myeloid malignancies
Li AW, Yin ES, Stahl M, Kim TK, Panse G, Zeidan AM, Leventhal JS. The skin as a window to the blood: Cutaneous manifestations of myeloid malignancies. Blood Reviews 2017, 31: 370-388. PMID: 28732587, DOI: 10.1016/j.blre.2017.07.003.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsCutaneous manifestationsMyeloid malignanciesMyeloid diseasesCommon cutaneous manifestationStage of diseaseHematologists/oncologistsSignificant clinical implicationsMalignant hematopoietic cellsCutaneous involvementSkin manifestationsTargeted agentsSkin findingsClinical reviewCutaneous reactionsDermatologic findingsPrognostic valueImmune statusDiagnostic challengeEarly recognitionHematologic malignanciesMalignancyClinical implicationsDiseaseManifestationsHematopoietic cells